Browsing by Author "Pizarro-Berdichevsky, Javier"

Now showing 1 - 3 of 3
  • Thumbnail Image
    Item
    Can Lumbosacral Magnetic Resonance Imaging be Performed Safely in Patients with a Sacral Neuromodulation Device? An In Vivo Prospective Study
    (2018) Guzman-Negron, Juan M.; Pizarro-Berdichevsky, Javier; Gill, Bradley C.; Goldman, Howard B.
  • No Thumbnail Available
    Item
    Levator Ani Avulsion in Ultrasound Increases Recurrence in Sacrospinous Fixation
    (2024) Maluenda, Andrea; Santis-Moya, Fernanda; Arevalo, Diego; Pohlhammer, Dominga; Blumel, Bernardita; Guzman-Rojas, Rodrigo; Pizarro-Berdichevsky, Javier
    Importance Pelvic floor translabial ultrasound (TLUS) can identify levator ani muscle (LAM) avulsion and ballooning, which some studies have shown to be possible risk factors for prolapse recurrence. Our group uses TLUS to counsel patients preoperatively. If any of these risk factors exist, we offer sacrocolpopexy over vaginal repair. However, some patients, even though they have these possible risk factors, prefer to undergo vaginal surgery. Objective The objective of this study was to determine if TLUS LAM avulsion and/or ballooning are risk factors for composite outcome recurrence in patients undergoing sacrospinous ligament fixation for pelvic organ prolapse. Study design This was a retrospective observational study. All patients with vaginal apical repair with sacrospinous ligament fixation with preoperative TLUS were included. Demographics, clinical characteristics, and follow-up were analyzed. Multivariable logistic regression analysis was performed for composite outcome that included TLUS risk factors, age, Pelvic Organ Prolapse Quantification System measurements and stage, and variables with P < 0.1 in the univariate analysis. Results Eighty-two patients were included. All patients had symptomatic vaginal bulge; 65.4% had stage III prolapse. Concomitant hysterectomy was performed in 54.3%. Median follow-up was 20 months (interquartile range, 8-35 months); 19.8% had LAM avulsion, and 43.2% had ballooning. Anatomic recurrence rate was 23.5%, symptomatic was 22.2%, and reoperation was 1.2%. The composite recurrence rate was 29.6%. In the multivariable logistic regression analysis, unilateral/bilateral avulsion in TLUS was found to be a significant risk factor for composite outcome with an odds ratio of 4.33 (confidence interval, 1.219-15.398; P = 0.023). Conclusions Composite outcome of recurrence in our study was 29.6%. Avulsion on TLUS increased the risk of recurrence of pelvic organ prolapse by fourfold.
  • No Thumbnail Available
    Item
    Sacral neuromodulation therapy for urinary and defecatory disorders: experience in a Latin American public hospital
    (2024) Mass-Lindenbaum, Marcelo; Arevalo-Vega, Diego; Aleuanlli, Isidora; Santis-Moya, Fernanda; Maluenda, Andrea; Dines, Eitan; Cohen-Vaizer, Miriam; Saavedra, Alvaro; Raby, Trinidad; Blumel, Bernardita; Cuevas, Rodrigo; Pohlhammer, Simone; Alarcon, Gabriela; Albornoz, Marco Arellano; Pizarro-Berdichevsky, Javier
    Objective: To To show the experience of a Latin American public hospital, with SNM in the management of either OAB, NOUR or FI, reporting feasibility, short to medium-term success rates, and complications. Methods: A retrospective cohort was conducted using data collected prospectively from patients with urogynecological conditions and referred from colorectal surgery and urology services between 2015 and 2022. Results: Advanced or basic trial phases were performed on 35 patients, 33 [94%] of which were successful and opted to move on Implantable Pulse Generator [GG] implantation. The average follow-up time after definitive implantation was 82 months (SD 59]. Of the 33 patients undergoing, 27 (81%]reported an improvement of 50% or more in their symptoms at last follow-up. Moreover, 30 patients (90%] with a definitive implant reported subjective improvement, with an average PGI-I "much better" and 9 of them reporting to be "excellent" on PGI-I. Conclusion: SNM is a feasible and effective treatment for pelvic floor dysfunction. Its implementation requires highly trained groups and innovative leadership. At a nation-wide level, greater diffusion of this therapy among professionals is needed to achieve timely referral of patients who require it.